Heat Biologics Inc.

AMEX: HTBX · Real-Time Price · USD
2.38
0.01 (0.42%)
At close: May 03, 2022, 6:00 AM

Heat Biologics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Cash & Equivalents
8.05M
Short-Term Investments
n/a
Long-Term Investments
88.32M
Other Long-Term Assets
-70.64M
Receivables
66.05K
Inventory
n/a
Other Current Assets
91.21M
Total Current Assets
99.33M
Property-Plant & Equipment
3.94M
Goodwill & Intangibles
n/a
Total Long-Term Assets
21.63M
Total Assets
120.96M
Account Payables
922.78K
Deferred Revenue
35K
Short-Term Debt
610.92K
Other Current Liabilities
3.15M
Total Current Liabilities
4.72M
Long-Term Debt
1.06M
Other Long-Term Liabilities
2.9M
Total Long-Term Liabilities
4.21M
Total Liabilities
8.93M
Total Debt
1.67M
Common Stock
5.05K
Retained Earnings
-165.72M
Comprehensive Income
-67.94K
Shareholders Equity
112.03M
Total Investments
88.32M